Article
Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
Archives of Iranian medicine - 1 Apr 2024
Saberzadeh-Ardestani Bahar, Khosravi Amir Ali, Mansour-Ghanaei Fariborz, Vahedi Homayoon, Baniasadi Nadieh, Seyyedmajidi Mohammadreza, Parhizkar Baran, Hormati Ahmad, Naghshbandi Sayed Jalalledin, Matin Somaieh, Hassan Zadeh Amir Abbas, Taghvaei Tarang, Bahrami Mohsen, Rafeey Mandana, Ahadi Mitra, Vossoughinia Hassan, Muosavi Hashem, Gheibi Shahsanam, Hosseini-Hemmatabadi Roya-Sadat, Yazdanbod Abbas, Matinkhah Saied, Sheikh Esmaeili Farshad, Fakheri Hafez, Moosavy Seyed Hamid, Maleki Iradj, Nasseri-Moghaddam Siavosh, Khosravi Bardia, Farahmand Fatemeh, Najafi Mehri, Alimadadi Hosein, Malekzadeh Masoud, Anushiravani Amir, Kasaeian Amir, Alatab Sudabeh, Sadeghi Anahita, Radmard Amir Reza, Kolahdoozan Shadi, Rajabi Zeynab, Sima Ali Reza
Abstract excerpt
BACKGROUND: Data on the epidemiology of inflammatory bowel disease (IBD) in the Middle East are scarce. We aimed to describe the clinical phenotype, disease course, and medication usage of IBD cases from Iran in the Middle East. METHODS: We conducted a cross-sectional study of registered IBD patients in the Iranian Registry of Crohn's and Colitis (IRCC) from 2017 until 2022. We collected information on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.